Concepedia

Scott D. Bercury

SD

12

Publications

1.5K

Citations

12

H-Index

2000

Active since

Affiliations

SynZyme Technologies (United States)(Current)

Harvard University

Massachusetts General Hospital

Scott D. Bercury is an author at SynZyme Technologies (United States) specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2000–2012

12

Publications

12

Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment

Andrew M. Tager, Shannon K. Bromley, Benjamin D. Medoff et al. · Nature Immunology · 2003 · 412 citations

, , +8

Inhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10

Andrew M. Tager, Richard L. Kradin, Peter LaCamera et al. · American Journal of Respiratory Cell and Molecular Biology · 2004 · 196 citations

Bltr Mediates Leukotriene B4–Induced Chemotaxis and Adhesion and Plays a Dominant Role in Eosinophil Accumulation in a Murine Model of Peritonitis

Andrew M. Tager, Jennifer Dufour, Katayoon Goodarzi et al. · The Journal of Experimental Medicine · 2000 · 195 citations · Full text

Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease

Yunxiang Zhu, Ji-Lei Jiang, Nathan Gumlaw et al. · Molecular Therapy · 2009 · 168 citations · Full text

Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene Therapy

Gregory D Hurlbut, Robin J. Ziegler, Jennifer B. Nietupski et al. · Molecular Therapy · 2010 · 134 citations · Full text

, , +16

Rows per page

1–5 of 12